Skip to main content
logo
QuadMedicine, Inc. (KOSDAQ:464490)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,080.00
-20.00 (-0.33%)
At close: Aug 11, 2026

QuadMedicine Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Revenue
9,78310,6989,3041,012
Revenue Growth
-2.76%14.99%819.58%-
Gross Profit
9,78310,6989,3041,012
Operating Income
-7,449-6,384-4,449-9,519
Net Income
-8,129-6,931-4,968-9,759
Earnings Per Share
-803.06-722.00-570.00-1130.00
EPS Growth
----

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
South Korea
10,1848,4581,012
Europe
514.05846.11-
Total
10,6989,3041,012

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Cash & Investments
24,45627,51710,2634,449
Total Debt
7,5467,4847,3636,423
Net Cash (Debt)
16,91020,0332,899-1,975
Net Cash Growth
-590.96%--
Net Cash Per Share
1670.092086.14332.59-228.65

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-4,315-4,5471,0721,760
Capital Expenditures
-2,342-2,191-3,286-11,817
Free Cash Flow
-6,657-6,738-2,214-10,056
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Gross Margin
100.00%100.00%100.00%100.00%
Operating Margin
-76.14%-59.67%-47.82%-940.90%
Pretax Margin
-83.10%-64.79%-53.40%-964.54%
Profit Margin
-83.10%-64.79%-53.40%-964.54%
FCF Margin
-68.05%-62.98%-23.80%-993.97%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
7.1416.53--